Asgedom Solomon Weldegebreal, Tesfaye Daniel, Nirayo Yirga Legesse, Atey Tesfay Mehari
School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia.
BMC Res Notes. 2018 Oct 4;11(1):696. doi: 10.1186/s13104-018-3806-7.
The main objective of this study was to assess time to death and associated risk factors among tuberculosis (TB) patients.
A total of 769 TB patients were studied and of those, 87 (11.3%) patients died. All of the deaths occurred within 7 months of anti-tuberculosis therapy. Extra-pulmonary TB (AHR = 17.376, 95% CI; 3.88-77.86, p < 0.001) as compared to pulmonary TB and cotrimoxazole prophylaxis therapy (CPT) (AHR = 0.15, 95% CI; 0.03-0.74, p = 0.02) were found to be the predictors of mortality. We noticed higher rates of mortality. Extra-pulmonary TB patients have high risk and TB-HIV co-infected patients who received CPT have low risk of death. Improving early diagnosis of extra-pulmonary TB and early CPT initiation of TB-HIV co-infected patients could minimize patient's mortality.
本研究的主要目的是评估结核病(TB)患者的死亡时间及相关危险因素。
共研究了769例结核病患者,其中87例(11.3%)死亡。所有死亡均发生在抗结核治疗的7个月内。与肺结核相比,肺外结核(调整后风险比[AHR]=17.376,95%置信区间[CI]:3.88 - 77.86,p<0.001)以及复方新诺明预防性治疗(CPT)(AHR=0.15,95%CI:0.03 - 0.74,p=0.02)被发现是死亡率的预测因素。我们注意到死亡率较高。肺外结核患者风险高,而接受CPT的结核病合并艾滋病病毒(TB-HIV)感染患者死亡风险低。改善肺外结核的早期诊断以及对TB-HIV合并感染患者尽早开始CPT治疗可使患者死亡率降至最低。